This proposed 3-arm randomized study will compare different pharmacy based approaches that include HIV prevention medication (PrEP and PEP), routine STI testing, and preventive antibiotic (doxycycline) for STIs. The study will assess how well these services can be implemented, how acceptable they are to young women, and whether they are cost-effective.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
HIV PrEP initiation
Timeframe: From enrollment to the end of participant follow up after 12 months
HIV PrEP persistence
Timeframe: From enrollment to the end of participant follow up at 12 months
STI incidence
Timeframe: From enrollment to the end of participant follow up at 12 months